Management Strategies of Intrapancreatic Mucinous Neoplasms (IPMNs)

An effective management of IPMNs requires a balance between the risk of malignant transformation and regular follow-up. It is influenced by lesion characteristics, patient health, and risk stratification. The key factors are High-Risk Stigmata: Main pancreatic duct diameter >10 mm, presence of an enhancing solid nodule, or obstructive jaundice associated with the cyst. Worrisome Features: Main pancreatic duct dilation (5–9 mm), mural nodules (<5 mm), cyst size >3 cm, or thickened cyst walls. Surveillance Protocols include as Low-risk IPMNs (no worrisome features): Monitor with annual magnetic resonance imaging (MRI) or endoscopic ultrasound (EUS). Moderate-risk IPMNs (worrisome features): Close monitoring every 3–6 months with MRI/EUS and biochemical markers like CA19-9. High-risk IPMNs: Immediate surgical evaluation and management. Surgical excision continues to be the mainstay of treatment for high-risk IPMNs. The location, size, and general health of the patient all influence the surgical treatment that is selected. Pancreaticoduodenectomy (Whipple Procedure) is ideal for lesions in the pancreatic head. Distal pancreatectomy is preferred for lesions in the body or tail, and total pancreatectomy is reserved for multifocal disease or extensive involvement but associated with significant morbidity, including diabetes and exocrine insufficiency.